Chagas disease as a mechanistic model for testing a novel hypothesis

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 1, 2008, Pages 70-72

  Mosovich, Serge A ^a   Mady, Charles ^b   Lopes, Neuza ^b   Ianni, Barbara ^b   Dias, João Carlos Pinto ^c   Correia, Dalmo ^d   Farkouh, Michael E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Chagas disease; Depression

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART DISEASE; HUMAN; INFLAMMATION; NOTE; RHEUMATOID ARTHRITIS; RISK FACTOR; TUBERCULOSIS;

EID: 41549156117     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000100013     Document Type: Note

References (36)

1. Aydin IO, Ulu_ahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. General Hospital Psychiatry 23: 77-83, 2001.
2. Becker R. What is a Platelet? How does it work? In: Cohen M (ed) Handbook of Antiplatelet Therapy. Martin Dunitz, 2003.
3. Black PH. Shedding from the cell surface of normal and cancer cells. Advances in Cancer Research 32: 75-199, 1980.
4. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R . Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389, 2003.
5. Cooper RS, Shamsi N, Katz S. Intracellular calcium and sodium in hypertensive patients. Hypertension 9: 224-229, 1987.
6. De Clerck F. Effects of serotonin on platelets and blood vessels. Journal of Cardiovascular Pharmacology 17(supl 5): S1-5, 1991.
7. Enzinger C, Wirleitner B, Spottl N, Böckb G, Fuchsa D, Baier-Bitterlich G. Reduced pteridine derivatives induce apoptosis in PC12 cells. Neurochemistry International 41: 71-78, 2002.
8. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. Journal of the American Medical Association 270: 1819-1825, 1993.
9. Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease. A 12-month follow-up. General Hospital Psychiatry 8: 61-65, 1996.
10. Hardardottir I, Grunfeld C, Feingold KR. Effects of endotoxin and cytokines on lipid metabolism. Current Opinion in Lipidology 5: 207-215, 1994.
11. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochemical Journal 265: 621-636, 1990.
12. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto Jr AM, Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96: 4219-4225, 1997.
13. Jiang W, Krishnan RR, O' Connor CM. Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs 16:111-127, 2002.
14. Kondo M, Oya-Ito T, Kumagai T, Osawa T, Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. Journal of Biological Chemistry 276: 12076-12083, 2001.
15. Konopka LM, Cooper R, Crayton JW. Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients. Biological Psychiatry 39: 708-713, 1996.
16. Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neuroscience 25: 154-159, 2002.
17. Kukin ML, Fuster V. Oxidative stress and cardiac failure. Futura Publishing, Armonk, Co, NY, Cap. xx, p. 291, 2003.
18. Liang MH, Rogers M, Larson M, Eaton HM, Murawski BJ, Taylor JE, Swafford J, Schur PH. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis & Rheumatism 27: 13-19, 1984.
19. Lustman PJ, Clouse RE. Depression in diabetes: the chicken or the egg? Psychosomatic Medicine 69: 297-299, 2007.
20. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Progress in Neuropsychopharmacology and Biological Psychiatry 19: 11-38, 1995.
21. Maes M, Scharpé S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche BV, Cosvns P. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Research 54: 143-160, 1994.
22. Mangone CA, Sica RE, Pereyra S, Genovese O, Segura E, Riarte A, Sanz OP, Segura M. Cognitive impairment in human chronic Chagas' disease. Arquivos de Neuro-Psiquiatria 52: 200-203, 1994.
23. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109-1123, 2007.
24. Miller GE, Rohleder N, Stetler C, Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosomatic Medicine 67: 679-687, 2005.
25. Oliveira TB, Pedrosa RC, W Filho D. Oxidative stress in chronic cardiopathy associated with Chagas disease. International Journal of Cardiology 116: 357-363, 2007.
26. Oliveira Jr W. O cardiopata chagásico em situações especiais. In: Dias JCP, Coura JR (orgs) Clinica e Terapêutica da Doença de Chagas: uma abordagem prática para o clínico geral. Editora Fundação Oswaldo Cruz, Rio de Janeiro, p. 293-320, 1997.
27. Opolski M, Wilson I. Asthma and depression: a pragmatic review of the literature and recommendations for future research. Clinical Practice and Epidemiology in Mental Health 1: 1-18, 2005.
28. Paneth N, Susser M. Early origins of coronary Heart disease (the "Barker Hypothesis") British Medical Journal 310: 411-412, 1995.
29. Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosomatic Medicine 65: 181-193, 2003.
30. Polley HF, Swenson WM, Steinhilber RM. Personality characteristics of patients with rheumatoid arthritis. Psychosomatics 11: 45-49, 1970.
31. Rugulies R. Depression as a predictor for coronary heart disease: a review and meta-analysis. American Journal of Preventive Medicine 23: 51-61, 2002.
32. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Progress in Neuropsychopharmacology and Biological Psychiatry 29: 201-217, 2005.
33. Tankova T, Koev D, Dakovska L. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study). Romanian Journal of Internal Medicine 42: 457-464, 2004.
34. Vanhoutte PM. Platelet-derived serotonin, the endothelium, and cardiovascular disease. Journal of Cardiovascular Pharmacology 17 (suppl 5): S6-12, 1991.
35. Wen JJ, Bhatia V, Popov VL, Garg NJ. Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease. American Journal of Pathology 169: 1953-1964, 2006.
36. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine 65: 201-210, 2003.